ADC Review | Journal of Antibody-drug Conjugates is an International, peer-reviewed publication designed to serve the needs of a diverse community of individuals, including academia. Life sciences, pharma, research, clinicians, and physicians, along with regulatory affairs, governing authorities and representatives from payers and policymakers. The journal focuses on all aspects of the development, manufacturing, clinical research, regulatory issues and marketing of ADCs.